Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after... Graefes Arch Clin Exp Ophthalmol (2017) 255:1713–1720 DOI 10.1007/s00417-017-3706-x RETINAL DISORDERS Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy? 1 2 1 1 Paolo Milani & Marco Pellegrini & Amedeo Massacesi & Stefania Moschini & 1 3 3 2 Marco Setaccioli & Davide Soranna & Antonella Zambon & Ferdinando Bottoni & Fulvio Bergamini Received: 3 March 2017 /Revised: 15 May 2017 /Accepted: 30 May 2017 /Published online: 30 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract and of lesion-adjacent ellipsoid zone at baseline were factors Purpose To evaluate functional prognostic factors and forbetterfinal BCVA (p ≤ 0.05) neuroretinal changes after anti-vascular endothelial growth Conclusion Vision gain might occur despite ellipsoid zone or factor (VEGF) treatment in patients with naïve, recent myopic ELM restoration. Hemorrhage could be considered a negative neovascularization (mCNV), as assessed by spectral-domain prognostic factor, integrity of lesion-adjacent ELM and of optical coherence tomography (SD-OCT). lesion-adjacent ellipsoid zone as positive prognostic factors. Methods Specific changes in tomographic features between Myopic CNV can also resolve completely without fibrosis. baseline and final follow-up were retrospectively evaluated . . by two examiners independently. Imaging was obtained by a Keywords Myopic neovascularization Pathologic myopia . . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Loading next page...
 
/lp/springer_journal/is-ellipsoid-zone-integrity-essential-for-visual-recovery-in-myopic-sCoKhxWh82
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3706-x
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial